Geminii, Inc.
Biotechnology company · Iowa City, Iowa, United States
Geminii, Inc. is a biotechnology company headquartered in Iowa City, Iowa, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $306,872 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2023.
Geminii at a glance
What does Geminii do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $306,872 in total (2025). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.1 million sold (2023).
Frequently asked questions about Geminii
Where is Geminii headquartered?
Geminii, Inc. is headquartered in Iowa City, Iowa, United States.
What does Geminii do?
Geminii, Inc. is a biotechnology company.
Similar companies
- SynderBio Inc.Iowa City, Iowa, United States
- Pxalpha, L.L.C.Iowa City, Iowa, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences